Study to Assess Antioxidant Efficacy of Spirulina on oxLDL and Lipids Metabolism on Subjects With Metabolic Syndrome

NCT02817620 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT: Spirulysat®
DIETARY_SUPPLEMENT: Placebo

Sponsor

Algosource

Collaborators

[object Object]